ScholarIQanswers from OpenAlex

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

PaperCitations, authors & open-access status

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era have?

ScholarIQcitation count

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era has 661 citations in the OpenAlex counts ScholarIQ stores.

When was Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era published?

ScholarIQyear

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era has 2008 year in the ScholarIQ index.

What is the open-access status of Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era?

ScholarIQoa status

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era has closed oa status in the ScholarIQ index.

What is the DOI of Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era?

ScholarIQdoi

The DOI for Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era is on the source record.

What is the PMID of Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era?

ScholarIQpmid

The PMID for Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era is on the source record.

What is the OpenAlex record for Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era?

ScholarIQopenalex

The OpenAlex for Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial